Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases
Jazyk angličtina Země Francie Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
R21 MH101673
NIMH NIH HHS - United States
R33 MH101673
NIMH NIH HHS - United States
PubMed
34102377
PubMed Central
PMC8373703
DOI
10.1016/j.ejmech.2021.113581
PII: S0223-5234(21)00430-X
Knihovny.cz E-zdroje
- Klíčová slova
- Acyclic nucleoside phosphonates, Adefovir, Adenylate cyclase, Bacillus anthracis, Bordetella pertussis, Inhibitors, Prodrugs,
- MeSH
- adenylátcyklasový toxin antagonisté a inhibitory metabolismus MeSH
- antibakteriální látky chemická syntéza chemie farmakologie MeSH
- Bacillus anthracis účinky léků MeSH
- Bordetella pertussis účinky léků enzymologie MeSH
- buněčné linie MeSH
- inhibitory adenylylcyklasy chemická syntéza chemie farmakologie MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- molekulární struktura MeSH
- myši MeSH
- neuralgie farmakoterapie MeSH
- organofosfonáty chemie farmakologie MeSH
- thiazoly chemie farmakologie MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- 2-aminothiazole MeSH Prohlížeč
- adenylátcyklasový toxin MeSH
- antibakteriální látky MeSH
- inhibitory adenylylcyklasy MeSH
- organofosfonáty MeSH
- thiazoly MeSH
A series of novel acyclic nucleoside phosphonates (ANPs) was synthesized as potential adenylate cyclase inhibitors, where the adenine nucleobase of adefovir (PMEA) was replaced with a 5-substituted 2-aminothiazole moiety. The design was based on the structure of MB05032, a potent and selective inhibitor of fructose 1,6-bisphosphatase and a good mimic of adenosine monophosphate (AMP). From the series of eighteen novel ANPs, which were prepared as phosphoroamidate prodrugs, fourteen compounds were potent (single digit micromolar or submicromolar) inhibitors of Bordetella pertussis adenylate cyclase toxin (ACT), mostly without observed cytotoxicity in J774A.1 macrophage cells. Selected phosphono diphosphates (nucleoside triphosphate analogues) were potent inhibitors of ACT (IC50 as low as 37 nM) and B. anthracis edema factor (IC50 as low as 235 nM) in enzymatic assays. Furthermore, several ANPs were found to be selective mammalian AC1 inhibitors in HEK293 cell-based assays (although with some associated cytotoxicity) and one compound exhibited selective inhibition of mammalian AC2 (only 12% of remaining adenylate cyclase activity) but no observed cytotoxicity. The mammalian AC1 inhibitors may represent potential leads in development of agents for treatment of human inflammatory and neuropathic pain.
Zobrazit více v PubMed
Khannpnavar B, Mehta V, Qi C, Korkhov V, Curr. Opin. Struct. Biol 2020, 63, 34–41 PubMed
Sadana R, Dessauer CW, Neurosignals 2009, 17, 5–22. PubMed PMC
Linder JU, Cell. Mol. Life. Sci 2006, 63, 1736–1751. PubMed PMC
Hanoune J, Defer N, Annu. Rev. Pharmacol. Toxicol 2001, 41, 145–174. PubMed
Sunahara RK, Dessauer CW, Gilman AG, Annu. Rev. Pharmacol. Toxicol 1996, 36, 461–480. PubMed
Ahuja N, Kumar P, Bhatnagar R, Crit. Rev. Microbiol 2004, 30, 187–196. PubMed
Ladant D, Ullmann A, Trends Microbiol. 1999, 7, 172–176. PubMed
Fedele G, Schiavoni I, Adkins I, Klimova N, Sebo P, Toxins 2017, 9, 293. PubMed PMC
Tang W-J, Guo Q, Mol. Asp. Med 2009, 30, 423–430. PubMed PMC
Seifert R, Dove S, Trends Microbiol. 2012, 20, 343–351. PubMed
Seifert R, Lushington GH, Mou T-C, Gille A, Sprang SR, Trends Pharmacol. Sci 2012, 33, 64–78. PubMed PMC
Brand CS, Hocker HJ, Gorfe AA, Cavasotto CN, Dessauer CW, J. Pharmacol. Exp. Ther 2013, 347, 265–275. PubMed PMC
Gille A, Seifert R, J. Biol. Chem 2003, 278, 12672–12679. PubMed
Gille A, Lushington GH, Mou TC, Doughty MB, Johnson RA, Seifert R, J. Biol. Chem 2004, 279, 19955–19969. PubMed
Taha HM, Schmidt J, Göttle M, Suryanarayana S, Shen Y, Tang W-J, Gille A, Geduhn J, König B, Dove S, Seifert R, Mol. Pharmacol 2009, 75, 693–703. PubMed PMC
Taha H, Dove S, Geduhn J, König B, Shen Y, Tang W-J, Seifert R, Naunyn-Schmiedeberg’s Arch. Pharmacol 2012, 385, 57–68. PubMed
Jiao G-S, Kim S, Moayeri M, Thai A, Cregar-Hernandez L, McKasson L, O’Malley S, Leppla SH, Johnson AT, Bioorg. Med. Chem. Lett 2018, 28, 134–139. PubMed PMC
De Clercq E, Holý A, Rosenberg I, Sakuma T, Balzarini J, Maudgal PC, Nature 1986, 323, 464–467. PubMed
Guo Q, Shen Y, Lee Y-S, Gibbs CS, Mrksich M, Tang W-J, EMBO J. 2005, 24, 3190–3201. PubMed PMC
Shen Y, Zhukovskaya NL, Zimmer MI, Soelaiman S, Bergson P, Wang C-R, Gibbs CS, Tang W-J, Proc. Natl. Acad. Sci. USA 2004, 101, 3242–3247. PubMed PMC
Šmídková M, Dvořáková A, Tloušt’ová E, Česnek M, Janeba Z, Mertlíková-Kaiserová H, Antimicrob. Agents Chemother 2014, 58, 664–671. PubMed PMC
Česnek M, Jansa P, Šmídková M Mertlíková-Kaiserová H, Dračínský M, Brust TF, Pávek P, Tretnar F, Watts VJ, Janeba Z, ChemMedChem 2015, 10, 1351–1364. PubMed
Česnek M, Skácel J, Jansa P, Dračínský M, Šmídková M, Mertlíková-Kaiserová H, Soto-Velasquez MP, Watts VJ, Janeba Z, ChemMedChem 2018, 13, 1779–1796. PubMed PMC
Břehová P, Šmídková M, Skácel J, Dračínský M, Mertlíková-Kaiserová H, Soto-Velasquez MP, Watts VJ, Janeba Z, ChemMedChem 2016, 11, 2534–2546. PubMed PMC
Frydrych J, Skácel J, Šmídková M, Mertlíková-Kaiserová H, Dračínský M, Gnanasekaran R, Lepšík M, Soto-Velasquez M, Watts VJ, Janeba Z, ChemMedChem 2018, 13, 199–206. PubMed
Erion MD, van Poelje PD, Dang Q, Kasibhatla SR, Potter SC, Reddy MR, Reddy KR, Jiang T, Lipscomb WN, PNAS, 2005, 102, 7970–7975. PubMed PMC
Dang Q, Kasibhatla SR, Reddy KR, Jiang T, Reddy MR, Potter SC, Fujitaki JM, van Poelje PD, Huang J, Lipscomb WN, Erion MD, J. Am. Chem. Soc 2007, 129, 15491–15502. PubMed
Dang Q, Kasibhatla SR, Jiang T, Fan K, Liu Y, Taplin F, Schulz W, Cashion DK, Reddy KR, van Poelje PD, Fujitaki JM, Potter SC, Erion MD, J. Med. Chem 2008, 51, 4331–4339. PubMed
Dang Q, Liu Y, Cashion DK, Kasibhatla SR, Jiang T, Taplin F, Jacintho JD, Li H, Sun Z, Fan Y, Da Re J, Tian F, Li W, Gibson T, Lemus R, van Poelje PD, Potter SC, Erion MD, J. Med. Chem 2011, 54, 153–165. PubMed
Jansa P, Baszczyňski O, Dračínský M, Votruba I, Zídek Z, Bahador G, Stepan G, Cihlar T, Mackman R, Holý A, Janeba Z, Eur. J. Med. Chem 2011, 46, 3748–3754. PubMed
Holý A, Rosenberg I, Collect. Czech. Chem. Commun 1987, 52, 2801–2809.
Karuvalam RP, Haridas KR, Nayak SK, Guru Row TN, Rajeesh P, Rishikesan R, Kumari NS, Eur. J. Mech. Chem 2012, 49, 172–182. PubMed
Pi Z, Sutton J, Lloyd J, Hua J, Price L, Wu Q, Chang M, Zheng J, Rehfuss R, Huang Ch. S., Wexler RR, Lam PYS, Bioorg. Med. Chem. Lett 2013, 23, 4206–4209. PubMed
Getlik M, Grutter C, Simard JR, Nguyen HD, Robubi A, Aust B, van Otterlo WAL, Rauh D, Eur. J. Med. Chem 2012, 48, 1–15. PubMed
Sperotto E, van Klink GPM, van Koten G, de Vries JG, Dalton Trans. 2010, 39, 10338–10351. PubMed
McKenna CE, Schmidhauser J, J. Chem. Soc., Chem. Commun 1979, 739.
Mackman RL, Zhang L, Prasad V, Boojamra CG, Douglas J, Grant D, Hui H, Kim CU, Laflamme G, Parrish J, Stoycheva AD, Swaminathan S, Wang KY, Cihlar T, Bioorg. Med. Chem 2007, 15, 5519–5528. PubMed
Brust TF, Alongkronrusmee D, Soto-Velasquez M, Baldwin TA, Ye Z, Dai M, Dessauer CW, van Rijn RM, Watts VJ, Sci. Signal 2017, 10, eaah5381. PubMed PMC
McGuigan C, Madela K, Aljarah M, Bourdin C, Arrica M, Barrett E, Jones S, Kolykhalov A, Bleiman B, Bryant KD, Ganguly B, Gorovits E, Henson G, Hunley D, Hutchins J, Muhammad J, Obikhod A, Patti J, Walters CR, Wang J, Vernachio J, Ramamurty CVS, Battina SK, Chamberlain S, J. Med. Chem 2011, 54, 8632–8645. PubMed
Pradere U, Garnier-Amblard EC, Coats SJ, Amblard F, Schinazi RF, Chem. Rev 2014, 114, 9154–9218. PubMed PMC
Watts VJ, Neuropsychopharmacol. 2018, 43, 215–216. PubMed PMC
Conley JM, Brand CS, Bogard AS, Pratt EPS, Xu R, Hockerman GH, Ostrom RS, Dessauer CW, Watts VJ, J. Pharmacol. Exp. Ther 2013, 347, 276–287. PubMed PMC